Transdermal Drug Delivery Research Report 2024-2030: Rising

Dublin, Oct. 3, 2024 (GLOBE NEWSWIRE) — The report “Transdermal Drug Delivery – Global Strategic Business Report” has been supplemented ResearchAndMarkets.com Offer.

The global transdermal drug delivery market was valued at $80.6 billion in 2023 and is expected to reach $235.3 billion by 2030, growing at a CAGR of 16.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts to help you make informed business decisions.

Transdermal drug delivery is a method of controlled administration of medications through the skin to achieve systemic effects. This delivery system is critical in providing a non-invasive, convenient and effective way to deliver drugs directly into the bloodstream, bypassing the gastrointestinal tract.

The growth of the transdermal drug delivery market is driven by several factors. The increasing prevalence of chronic diseases and conditions requiring long-term medication creates a significant need for effective and convenient drug delivery systems. Technological advances in drug formulation, skin penetration enhancement, and patch design are improving the effectiveness and reach of transdermal delivery systems and driving their acceptance. The focus on improving patient compliance and the need for non-invasive drug delivery options are also contributing to market growth.

The increasing applications of transdermal systems, including pain management, hormone replacement therapy and smoking cessation, continue to drive demand. In addition, favorable regulatory measures and the development of novel transdermal technologies support market expansion. The growing acceptance of transdermal drug delivery in the healthcare industry as well as ongoing research and development efforts to improve its performance and reliability highlight the growth potential of the market.

How does transdermal drug delivery improve therapy outcomes?

Transdermal drug delivery improves therapeutic outcomes through controlled and sustained drug release. This method of administration ensures that medications are absorbed evenly and optimal therapeutic concentrations are maintained in the bloodstream, increasing effectiveness and reducing dosing frequency.

By bypassing the gastrointestinal tract, transdermal systems avoid problems such as gastric irritation and first-pass metabolism, which can cause the drug to be broken down before it reaches the systemic circulation. This leads to better bioavailability and lower dosage requirements. Additionally, transdermal patches are user-friendly and self-administered, improving patient compliance with prescribed treatment regimens. Together, these advantages contribute to more effective and reliable therapeutic results.

Why is the demand for transdermal drug delivery systems increasing?

The demand for transdermal drug delivery systems is increasing due to several key factors. The increasing prevalence of chronic diseases and conditions requiring long-term drug treatment increases the need for convenient and effective methods of drug delivery. Advances in drug formulation and skin penetration technology have expanded the range of drugs that can be delivered transdermally, thereby increasing their applicability. The focus on improving patient compliance and reducing the burden of frequent dosing regimens is also driving demand for transdermal systems.

Additionally, the non-invasive nature of transdermal drug delivery makes it an attractive option for patients who prefer to avoid injections or oral medications. The development of novel transdermal technologies and the growing acceptance of these systems in the healthcare industry further support their introduction.

Key Takeaways:

• Market Growth: Understand the significant growth trajectory of the passive delivery segment, which is expected to reach $123.5 billion by 2030 at a compound annual growth rate of 15.1%. The Active Delivery segment is also expected to grow at a CAGR of 18.4% during the analysis period.
• Regional analysis: Get insights into the US market, valued at $22.1 billion in 2023, and China, which is expected to grow at an impressive 15.7% annually to $35.6 billion by 2030. Dollar is forecast. Discover growth trends in other key regions including Japan and Canada, Germany and Asia Pacific.

Reporting features:

• Comprehensive market data: Independent analysis of annual sales and market forecasts in millions of US dollars from 2023 to 2030.
• Detailed Regional Analysis: Detailed insights into key markets including the US, China, Japan, Canada, Europe, Asia Pacific, Latin America, the Middle East and Africa.
• Company Profiles: Coverage of key players such as Antares Pharma, Inc., Bayer AG, Durect Corporation and more.
• Free Updates: Receive one year of free report updates to keep you up to date on the latest market developments.

Key attributes:

Main topics covered:

MARKET OVERVIEW

• Insights into the influencer market
• World market trends
• Transdermal Drug Delivery Percentage Market Share of Key Global Competitors in 2024 (E)
• Global economic update
• Competitive market presence – strong/active/niche/trivial for players worldwide in 2024 (E)

Market trends and drivers

• Growing preference for non-invasive drug delivery methods
• Advances in patch technology and formulations
• Increasing incidence of chronic diseases
• Increasing demand for controlled release and targeted delivery
• Expansion of applications beyond pain therapy
• Market Growth in the Geriatric and Pediatric Population
• Impact of biotechnological and nanotechnological innovations

Focus on selected players(12 featured in total)

• Antares Pharma, Inc.
• Bayer AG
• Durect Corporation
• Iontera, Inc.
• Janssen Pharmaceuticals, Inc.
• Nitto Denko Corporation
• Novartis AG
• Pantec Biosolutions AG
• Tesa Labtec GmbH
• Teva Pharmaceutical Industries Ltd.

For more information about this report, see

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

• Transdermal drug delivery market